Northwestern Mutual Wealth Management’s Filana Therapeutics FLNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-12
Closed -$353 3846
2024
Q3
$353 Buy
+12
New +$276 ﹤0.01% 3376
2024
Q2
Sell
-70
Closed -$1.42K 3783
2024
Q1
$1.42K Sell
70
-145
-67% -$3.34K ﹤0.01% 3117
2023
Q4
$4.84K Buy
+215
New +$4.54K ﹤0.01% 2869
2023
Q1
Sell
-2
Closed -$60 3558
2022
Q4
$60 Buy
+2
New +$72 ﹤0.01% 3243
2022
Q2
Sell
-123
Closed -$5K 3434
2022
Q1
$5K Buy
+123
New +$5.21K ﹤0.01% 2758

Other funds holding FLNA

Northwestern Mutual Wealth Management's FLNA Position: Q4 2024 in Review

Northwestern Mutual Wealth Management sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 12 shares — an estimated $353 sold.

Northwestern Mutual Wealth Management first reported a position in FLNA in Q1 2022 and held it in 5 quarters. The position peaked at $5K in Q1 2022. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • Northwestern Mutual Wealth Management reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 12 Filana Therapeutics shares in Q4 2024, an estimated $353.
  • Northwestern Mutual Wealth Management first reported a position in Filana Therapeutics in Q1 2022 and held it in 5 quarters.
  • Northwestern Mutual Wealth Management's Filana Therapeutics position peaked at $5K in Q1 2022.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on Northwestern Mutual Wealth Management's 13F filing for Q4 2024, filed 11 Feb 2025.